ton rabelink

Ton Rabelink has a strong background in the medical field, with extensive work experience in various roles. ton is currently serving as the Node Director at the Novo Nordisk Foundation Center for Stem Cell Medicine – reNEW since January 2022. Prior to that, they were the Chief Scientific Officer & Founder of NecstGen from January 2020. Ton Rabelink also holds the position of Professor of Medicine at Leiden University Medical Center since February 2004. ton has made significant contributions to the field, as evidenced by their role description available on the Leiden University Medical Center website.

Ton Rabelink has a degree in Medicine from Utrecht University.